EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Global Health Economics and Sustainability

ISSN 2972-4570 · AccScience Publishing

Latest articles

  1. Budgetary impact of new label indications after initial drug registration in Brazil: A case study of pembrolizumab and trastuzumab deruxtecan

    Marcus Carvalho Borin, Mariana Michel Barbosa, Camila Oliveira Pereira, Carina Rejane Martins, Daniel Pitchon dos Reis, Geraldo José Coelho Ribeiro, Júlia Teixeira Tupinambás, Karina de Castro Zocrato, Lélia Maria de Almeida Carvalho, Marcela Pinto de Freitas, Maria da Glória Cruvinel Horta, Mariza Cristina Torres Talim, Ernesto Gomes de Azevedo, Sergio Adriano Loureiro Bersan, Silvana Marcia Bruschi Kelles

    Published: 2023DOI: 10.36922/ghes.0994

  2. Assessing the impact of fast-track drug registration by Anvisa in Brazil: A descriptive study of new drug registrations from 2017 to 2022

    Marcus Carvalho Borin, Mariana Michel Barbosa, Camila Oliveira Pereira, Carina Rejane Martins, Daniel Pitchon dos Reis, Geraldo José Coelho Ribeiro, Júlia Teixeira Tupinambás, Karina de Castro Zocrato, Lélia Maria de Almeida Carvalho, Arcela Pinto de Freitas, Maria da Glória Cruvinel Horta, Mariza Cristina Torres Talim, Ernesto Gomes de Azevedo, Sergio Adriano Loureiro Bersan, Silvana Marcia Bruschi Kelles

    Published: 2023DOI: 10.36922/ghes.0995

Volumes

2026 · 172025 · 452024 · 942023 · 19

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.